NZ247068A - Benzofuranylmethylthiazolidinedione derivatives and medicaments. - Google Patents

Benzofuranylmethylthiazolidinedione derivatives and medicaments.

Info

Publication number
NZ247068A
NZ247068A NZ247068A NZ24706893A NZ247068A NZ 247068 A NZ247068 A NZ 247068A NZ 247068 A NZ247068 A NZ 247068A NZ 24706893 A NZ24706893 A NZ 24706893A NZ 247068 A NZ247068 A NZ 247068A
Authority
NZ
New Zealand
Prior art keywords
formula
compound
compounds
thiazolidinedione
pharmaceutically acceptable
Prior art date
Application number
NZ247068A
Other languages
English (en)
Inventor
Nanteuil Guillaume De
Denis Ravel
Jacques Duhault
Joseph Espinal
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of NZ247068A publication Critical patent/NZ247068A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NZ247068A 1992-03-06 1993-03-05 Benzofuranylmethylthiazolidinedione derivatives and medicaments. NZ247068A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9202671A FR2688220A1 (fr) 1992-03-06 1992-03-06 Nouveaux derives de thiazolidine-2,4-dione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Publications (1)

Publication Number Publication Date
NZ247068A true NZ247068A (en) 1994-01-26

Family

ID=9427406

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ247068A NZ247068A (en) 1992-03-06 1993-03-05 Benzofuranylmethylthiazolidinedione derivatives and medicaments.

Country Status (7)

Country Link
EP (1) EP0559571A1 (enrdf_load_stackoverflow)
JP (1) JPH069629A (enrdf_load_stackoverflow)
AU (1) AU654899B2 (enrdf_load_stackoverflow)
CA (1) CA2091127A1 (enrdf_load_stackoverflow)
FR (1) FR2688220A1 (enrdf_load_stackoverflow)
NZ (1) NZ247068A (enrdf_load_stackoverflow)
ZA (1) ZA931593B (enrdf_load_stackoverflow)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4317320A1 (de) * 1993-05-25 1994-12-01 Boehringer Mannheim Gmbh Neue Thiazolidindione und diese enthaltende Arzneimittel
DK0719140T3 (da) * 1993-09-15 2008-03-03 Daiichi Sankyo Co Ltd Anvendelse af thiazolidindioner til forebyggelse eller forsinkelse af indtræden af NIDDM
CA2171702A1 (en) * 1995-03-14 1996-09-15 Takashi Sohda Benzofuran compounds and their use
DE19711616A1 (de) 1997-03-20 1998-09-24 Boehringer Mannheim Gmbh Verbessertes Verfahren zur Herstellung von Thiazolidindionen
EP0977753A1 (en) * 1997-12-02 2000-02-09 Dr. Reddy's Research Foundation Azolidinediones useful for the treatment of diabetes, dyslipidemia and hypertension
WO1999057117A2 (de) 1998-05-04 1999-11-11 Asta Medica Aktiengesellschaft Indolderivate und deren verwendung zur behandlung von malignen und anderen, auf pathologischen zellproliferationen beruhenden erkrankungen
AU6331099A (en) * 1998-09-30 2000-04-17 Roche Diagnostics Gmbh Thiazolidine derivatives for the treatment and prevention of metabolic bone disorders
US6756360B1 (en) 1998-12-24 2004-06-29 Metabasis Therapeutics, Inc. Combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetes
US7563774B2 (en) 2000-06-29 2009-07-21 Metabasis Therapeutics, Inc. Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986007056A1 (en) * 1985-05-21 1986-12-04 Pfizer Inc. Hypoglycemic thiazolidinediones
GB8713861D0 (en) * 1987-06-13 1987-07-15 Beecham Group Plc Compounds

Also Published As

Publication number Publication date
AU3400893A (en) 1993-09-09
FR2688220B1 (enrdf_load_stackoverflow) 1995-06-02
ZA931593B (en) 1993-09-27
EP0559571A1 (fr) 1993-09-08
CA2091127A1 (fr) 1993-09-07
FR2688220A1 (fr) 1993-09-10
AU654899B2 (en) 1994-11-24
JPH069629A (ja) 1994-01-18

Similar Documents

Publication Publication Date Title
EP0528734B1 (fr) Dérivés de 2,4-thiazolidinedione, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
ZA200510294B (en) Hexahydropyridoisoquinolines as DPP-IV inhibitors
DE69715009T2 (de) Substituierte thiazolidinedione derivate, ihre herstellung und pharmazeutische zusammensetzungen, die sie enthalten
AU654899B2 (en) New 2,4-thiazolidinedione compounds, process for preparing them and pharmaceutical compositios containing them
JP2650038B2 (ja) ピロリチジン化合物およびその用途
Cannon et al. Congeners of the. beta. conformer of dopamine derived from cis-and trans-octahydrobenzo [f] quinoline and trans-octahydrobenzo [g] quinoline
EP0543713B1 (fr) Nouveaux dérivés de benzoate d'éthanolamine, leur procédé de préparation et les compositions pharmaceutiques les renfermant
US4134991A (en) Derivatives of 2-(3-phenyl-2-aminopropionyloxy)-acetic acid
DE19831878A1 (de) Polycyclische Thiazolidin-2-yliden Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
JP2001514632A (ja) 新規ヘテロサイクリック化合物
WO2000051579A2 (de) Verwendung von polycyclischen thiazol-systemen zur herstellung von medikamenten zur prophylaxe oder behandlung von obesitas
CA2108064C (fr) Nouveaux composes de thiazolidine dione, leur procede de preparation et les compositions pharmaceutiques les contenant
CN1989090B (zh) 顺式-1,2-取代的二苯乙烯衍生物及其用于制备治疗和/或预防糖尿病的药物的用途
JPS6011898B2 (ja) 新ベンゼンスルホンアミド誘導体、それらの製造法およびそれらを含有する医薬組成物
CZ286649B6 (cs) 2-(aminomethyl)-3,4,7,9-tetrahydro-2H-pyrano-/2,3-e/indol-8-onové deriváty a farmaceutický prostředek s jejich obsahem
US5464859A (en) Benzospiroalkene derivatives
CN100349881C (zh) 取代五元氮杂环盐类化合物及其治疗蛋白老化相关疾病的用途
EP0430800B1 (fr) Nouvelles benzothiazolinones substituées, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
US4503058A (en) Therapeutically useful 3,7a-diazacyclohepta[j,k]fluorene derivatives
EP0518769B1 (fr) Nouveaux dérivés de benzoate d'éthanolamine, leur procédé de préparation et les compositions pharmaceutiques les renfermant
US4349547A (en) Suppressing obesity and over-secretion of insulin with 2-(α-hydroxy-m-trifluoromethylbenzyl)azetidine
NZ199008A (en) 2,3,3a,4,5,6-hexahydro-ih-indolo(3,2,1-de)(1,5)-naphthyridines
CZ20023718A3 (cs) Opticky aktivní 2-aminotetralinové deriváty, způsob jejich výroby a farmaceutický prostředek
EP0745597A2 (en) Novel melatonergic indanyl piperazines or homopiperazines
LU80712A1 (fr) Composes polyfluorohydroxyisopropyl carbostyriles tricycliques antihypertensifs,leur preparation et compositions pharmaceutiques les contenant